In some respects, it is a little surprising that Varian Medical (NYSE: VAR ) is near an all-time high. Revenue and order growth haven't been all that robust lately, rivals like Accuray (NASDAQ: ARAY ) and Elekta
appear to have some renewed vitality, and reimbursement in the U.S. is
still choppy. Then again, we're talking about a company that has more
than 50% global installed share in radiation oncology systems, a long
record of 20%-plus returns on invested capital, and a well-deserved
reputation as a "fast follower" with good technology, strong service,
and demonstrated reliability.
Please continue here:
http://www.fool.com/investing/general/2013/10/09/varian-medical-still-the-dominant-player-in-a-lucr.aspx
No comments:
Post a Comment